Trial · NCT01447628
Outcomes32
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 32
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Exercise Capacity - Endurance | 12 Weeks post study treatment | Intention to treat (ITT) | Seconds | LEAST_SQUARES_MEAN |
| PRIMARY | Change in Resting Pulmonary Vascular Resistance (PVR) | 12 weeks post study treatment | Wood units | MEAN | |
| SECONDARY | Oxygen Consumption (VO2) Level at Peak 12 Weeks After Study Treatment | 12 weeks post study treatment | Litres per minute | MEAN | |
| SECONDARY | Oxygen Consumption (VO2) at Metabolic Threshold | 12 weeks post study treatment | Litres per minute | MEAN | |
| SECONDARY | Ventilation / Volume of Exhaled Carbon Dioxide (VE/VCO2 Slope) | 12 weeks post study treatment | l/min/l/min | MEAN | |
| SECONDARY | Oxygen Consumption (VO2) / Work Rate (WR) Slope | 12 weeks post study treatment | ml/min/watt | MEAN | |
| SECONDARY | Peak Oxygen (O2) Pulse Rate | 12 weeks post study treatment | ml/beat | LEAST_SQUARES_MEAN | |
| SECONDARY | Oxygen Consumption (VO2) at the End of Endurance Cardio-pulmonary Exercise Test (CPET) | 12 weeks post study treatment | Litres per minute | LEAST_SQUARES_MEAN | |
| SECONDARY | Oxygen Consumption (VO2) at 3 Minutes | 12 weeks post study treatment | Litres per minute | LEAST_SQUARES_MEAN | |
| SECONDARY | Iron Indices: Serum Iron | 12 weeks post study treatment | umol/L | MEAN | |
| SECONDARY | Iron Indices: Transferrin Saturations | 12 weeks post study treatment | percentage of iron occupied transferrin | MEAN | |
| SECONDARY | Iron Indices: Ferritin | 12 weeks post study treatment | ug/L | MEAN | |
| SECONDARY | Iron Indices: Soluble Transferrin Receptors (sTfR) | 12 weeks post study treatment | nmol/L | MEAN | |
| SECONDARY | 6 Minute Walk Test: Distance Walked | 12 weeks post study treatment | Metres | MEAN | |
| SECONDARY | 6 Minute Walk Test: Borg Dyspnoea Score After Test | 12 weeks post study treatment | units on a scale | MEAN | |
| SECONDARY | Iron Indices: N-terminal Pro B-type Natriuretic Peptide (NT-pro-BNP) | 12 weeks post study treatment | fmol/ml | MEAN | |
| SECONDARY | Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR Questionnaire): Symptom Score | 12 weeks post study treatment | score on a scale | MEAN | |
| SECONDARY | Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR Questionnaire): Activity Score | 12 weeks post study treatment | units on a scale | MEAN | |
| SECONDARY | Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR Questionnaire): QoL Score | 12 weeks post study treatment | units on a scale | MEAN | |
| SECONDARY | Mean Right Atrial Pressure (Cardiac Catheter) | 12 weeks post study treatment | mmHg | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01447628/outcomes